Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351 (2021)

First Author: Sziemel A

Attributed to: A One Health approach to pan-valent morbillivirus vaccines funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.04.11.439360

Publication URI: http://dx.doi.org/10.1101/2021.04.11.439360

Type: Preprint